Center-Authored Papers

Browse: Authors | Keywords | All Center-Authored Publications
Filter by Division: Basic | Clinical | Human Biology | PHS | VIDD (2010-present) | VIDI (2008-2009)
Filter by Year: 2008 | 2009 | 2010 | 2011 | 2012 | 2013

Filters: Author is Bleakley, Marie  [Clear All Filters]
B
Bleakley, M, Riddell SR.  2011.  Exploiting T cells specific for human minor histocompatibility antigens for therapy of leukemia.. Immunology and cell biology. 89(3):396-407. Abstract
Bleakley, M, Turtle CJ, Riddell SR.  2012.  Augmentation of anti-tumor immunity by adoptive T-cell transfer after allogeneic hematopoietic stem cell transplantation.. Expert review of hematology. 5(4):409-25. Abstract
Bleakley, M, Otterud BE, Richardt JL, Mollerup AD, Hudecek M, Nishida T, Chaney CN, Warren EH, Leppert MF, Riddell SR.  2010.  Leukemia-associated minor histocompatibility antigen discovery using T-cell clones isolated by in vitro stimulation of naive CD8+ T cells.. Blood. 115(23):4923-33. Abstract
H
Hudecek, M, Schmitt TM, Baskar S, Lupo-Stanghellini MT, Nishida T, Yamamoto TN, Bleakley M, Turtle CJ, Chang W-C, Greisman HA et al..  2010.  The B-cell tumor-associated antigen ROR1 can be targeted with T cells modified to express a ROR1-specific chimeric antigen receptor.. Blood. 116(22):4532-41. Abstract
L
Li, Y, Bleakley M, Yee C.  2005.  IL-21 influences the frequency, phenotype, and affinity of the antigen-specific CD8 T cell response.. Journal of immunology (Baltimore, Md. : 1950). 175(4):2261-9. Abstract
N
Nishida, T, Hudecek M, Kostic A, Bleakley M, Warren EH, Maloney DG, Storb R, Riddell SR.  2009.  Development of tumor-reactive T cells after nonmyeloablative allogeneic hematopoietic stem cell transplant for chronic lymphocytic leukemia.. Clinical cancer research : an official journal of the American Association for Cancer Research. 15(14):4759-68. Abstract
O
Ochsenreither, S, Majeti R, Schmitt T, Stirewalt D, Keilholz U, Loeb KR, Wood B, Choi YE, Bleakley M, Warren EH et al..  2012.  Cyclin-A1 represents a new immunogenic targetable antigen expressed in acute myeloid leukemia stem cells with characteristics of a cancer-testis antigen.. Blood. 119(23):5492-501. Abstract
P
Pollack, SM, Jungbluth AA, Hoch BL, Farrar EA, Bleakley M, Schneider DJ, Loggers ET, Rodler E, Eary JF, Conrad Iii EU et al..  2012.  NY-ESO-1 is a ubiquitous immunotherapeutic target antigen for patients with myxoid/round cell liposarcoma.. Cancer. Abstract